Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T17:31:34.782Z.
Calculation as of: 2026-10-06T17:31:34.782Z.
Quote observation: 2026-10-06T17:29:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4140271b5ba2e17517ffa776ba39ee0784cb590c71b20d0313403f3757235181
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$1.14B
Price/OCF Ratio
5.65
TTM Avg
5.50
3Y Avg
12.06
5Y Avg
21.65
Market Cap
$1.14B
Price/OCF Ratio
6.16
TTM Avg
6.67
3Y Avg
9.62
5Y Avg
13.32
Market Cap
$1.13B
Price/OCF Ratio
180.29
TTM Avg
131.82
3Y Avg
1823.85
5Y Avg
1138.24
Market Cap
$1.12B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12B
Price/OCF Ratio
N/A
TTM Avg
73.98
3Y Avg
165.41
5Y Avg
108.12
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.17B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.14B | N/A | 9.13 | 9.13 | 9.13 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 5.65 | 5.50 | 12.06 | 21.65 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 6.16 | 6.67 | 9.62 | 13.32 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 180.29 | 131.82 | 1823.85 | 1138.24 |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.21B | N/A | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.12B | N/A | N/A | N/A | N/A |
| MannKind Corporation (MNKD)vs › | $1.21B | N/A | 46.69 | 49.24 | 49.24 |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.12B | N/A | 73.98 | 165.41 | 108.12 |
| Cronos Group Inc. (CRON)vs › | $1.22B | 20.24 | 36.33 | 71.26 | 71.26 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
